Piscataway, N.J.– Camber Pharmaceuticals is pleased to announce the addition of atovaquone oral solution to our growing portfolio of products. Atovaquone oral solution is the generic version of Mepron from GlaxoSmithKline and is used to treat or prevent pneumonia caused by a fungal infection called Pneumocystis carinii. Atovaquone oral solution is available in 750 mg/5 mL bottles.

Camber said its commitment to its customers is to bring the highest quality generic pharmaceuticals to the market and provide a level of excellence in service, supply and affordability.